Launching
Myeloma
Research
Across Canada
Launching
Myeloma Research
Across Canada
At the Canadian Myeloma Research Group (CMRG), we are deeply committed to advancing research and improving treatments for multiple myeloma, a complex and challenging form of blood cancer.
Our team, comprised of top-tier researchers, clinicians, and healthcare professionals across Canada, works tirelessly to stay at the forefront of medical science and patient care.
25⁺
Participating Centres
22k⁺
Cycles of Treatment to Date
27
Manuscripts Published
600⁺
Patients enrolled
25⁺
Participating Centres
22k⁺
Cycles of Treatment to Date
27
Manuscripts Published
600⁺
Patients enrolled
These numbers reflect the real impact of CMRG’s work.
Each trial, patient, and publication represents progress in advancing myeloma research across Canada. Together, they demonstrate the scope of collaboration, the lives touched through innovative treatments, and the evidence driving breakthroughs towards better care and a future cure.
Recent News
Research Opportunity – Multiple Myeloma Interview Study
Individuals in Canada who are currently receiving or have previously received belantamab mafodotin for multiple myeloma (MM) may be eligible to participate in a...
New Study Published in Clinical Lymphoma Myeloma & Leukemia
We are pleased to share that the study Real-World Outcomes in Myeloma Patients With t(11;14): A Matched Comparison Using the Canadian Myeloma Research Group National...
News Announcement — September 2025
We are delighted to announce that a poster on Tumor-reactive γδ T Cells Mediate Responses to the Antibody Drug Conjugate Belantamab Mafodotin in Multiple Myeloma was...
The Trial to Triumph Gala 2026
We are delighted to officially invite our patients, researchers, healthcare professionals, and dedicated supporters to join us for an evening of elegance, entertainment, and profound purpose. The Trial to Triumph Gala brings our community together under one roof to celebrate resilience and drive progress, with all proceeds directly supporting the advancement of critical myeloma research and patient care. Event Details Date: Friday, October 23rd, 2026 Venue: Park Hyatt Hotel Attire: Gala / Formal What to Expect Prepare for a beautifully curated night designed to inspire and entertain: 🎻 Live Entertainment: Dance and celebrate with a live band and professional DJ. 🥂 Fine Dining: Enjoy a premier dinner service accompanied by an open bar. 🎁 Silent Auction: Bid on exclusive items and experiences in support of our mission. ✨ Special Guests: Connect during an exclusive meet-and-greet with local celebrities and capture the memories at our dedicated photo opportunities. Secure Your Tickets...
The Trial to Triumph Gala 2026
We are delighted to officially invite our patients, researchers, healthcare professionals, and dedicated supporters to join us for an evening of elegance, entertainment, and profound purpose. The Trial to Triumph Gala brings our community together under one roof to...
Upcoming Clinical Trials
CMRG is continually expanding access to life‑changing myeloma research.
Our expert team develops and oversees clinical trials across Canada, with over 350 patients treated to date. Listed below are our upcoming clinical trials as we continue to grow our portfolio each year.
Sarah’s Journey
When Sarah was diagnosed with myeloma at 52, she felt her world shift overnight. Through a CMRG clinical trial, she gained access to a new treatment that not only extended her remission but allowed her to maintain her active lifestyle.
The options offered to me through the trial gave me renewed hope. I felt empowered knowing there was a team working together to fight for my future,” Sarah shares.
Her story reflects the impact CMRG research can have – turning groundbreaking studies into real hope for patients and their families.
Frequently Asked Questions
This FAQ section provides clear, straightforward answers about our work, our approach, and how research helps improve outcomes for patients and families.